BRAF and cancer: In some cancers such as advanced melanoma, V600 mutations occur at particularly higher rates in adolescents and young adults when compared to older adults (68% vs. 46%, p < 0.001) [125], identifying age as a potential biomarker for the presence of the BRAF V600E mutation in these tumors.